BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25622542)

  • 1. Functional genomics analysis reveals a MYC signature associated with a poor clinical prognosis in liposarcomas.
    Tran D; Verma K; Ward K; Diaz D; Kataria E; Torabi A; Almeida A; Malfoy B; Stratford EW; Mitchell DC; Bryan BA
    Am J Pathol; 2015 Mar; 185(3):717-28. PubMed ID: 25622542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
    Creytens D; Van Gorp J; Speel EJ; Ferdinande L
    Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No correlation of c-myc overexpression and p53 mutations in liposarcomas.
    Schneider-Stock R; Walter H; Rys J; Radig K; Hoang-Vu C; Roessner A
    Virchows Arch; 1998 Oct; 433(4):315-21. PubMed ID: 9808433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
    Boland JM; Colby TV; Folpe AL
    Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleomorphic liposarcoma.
    Oliveira AM; Nascimento AG
    Semin Diagn Pathol; 2001 Nov; 18(4):274-85. PubMed ID: 11757868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
    Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
    Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep-seated, well differentiated lipomatous tumors of the chest wall and extremities: the role of cytogenetics in classification and prognostication.
    Bassett MD; Schuetze SM; Disteche C; Norwood TH; Swisshelm K; Chen X; Bruckner J; Conrad EU; Rubin BP
    Cancer; 2005 Jan; 103(2):409-16. PubMed ID: 15593324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas.
    Deyrup AT; Chibon F; Guillou L; Lagarde P; Coindre JM; Weiss SW
    Am J Surg Pathol; 2013 Sep; 37(9):1373-8. PubMed ID: 23887155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of genes over-expressed in myxoid/round cell liposarcoma. DNA microarray analysis and immunohistochemical correlation].
    Lanckohr C; Kasprzynski A; Klein-Hitpass L; Homann HH; Lehnhardt M; Müller O; Kuhnen C; Herter P
    Pathologe; 2010 Feb; 31(1):60-6. PubMed ID: 19823827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soft tissue liposarcoma: histological subtypes, MRI and CT findings.
    Barile A; Zugaro L; Catalucci A; Caulo M; Di Cesare E; Splendiani A; Gallucci M; Masciocchi C
    Radiol Med; 2002 Sep; 104(3):140-9. PubMed ID: 12471362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
    Cheng H; Dodge J; Mehl E; Liu S; Poulin N; van de Rijn M; Nielsen TO
    Hum Pathol; 2009 Sep; 40(9):1244-51. PubMed ID: 19368956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin resistance in a novel in vitro model of human pleomorphic liposarcoma associated with alternative lengthening of telomeres.
    Mitchell MA; Johnson JE; Pascarelli K; Beeharry N; Chiourea M; Gagos S; Lev D; von Mehren M; Kipling D; Broccoli D
    Mol Cancer Ther; 2010 Mar; 9(3):682-92. PubMed ID: 20197395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with outcome in liposarcomas of the extremities and trunk.
    Pakos EE; Gogou PV; Apostolikas N; Batistatou A; Tsekeris PG
    J BUON; 2010; 15(3):518-23. PubMed ID: 20941821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between expression of c-myc and p53 in liposarcoma].
    Wang YL; Qiu JS; Xiong M
    Ai Zheng; 2002 Jan; 21(1):63-7. PubMed ID: 12500400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic findings in liposarcoma correlate with histopathologic subtypes.
    Sreekantaiah C; Karakousis CP; Leong SP; Sandberg AA
    Cancer; 1992 May; 69(10):2484-95. PubMed ID: 1568170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
    Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
    J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic features of pediatric soft-tissue sarcomas.
    Neifeld JP; Godwin D; Berg JW; Salzberg AM
    Surgery; 1985 Jul; 98(1):93-7. PubMed ID: 4012611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of histologic subtypes in primary extremity liposarcoma.
    Chang HR; Hajdu SI; Collin C; Brennan MF
    Cancer; 1989 Oct; 64(7):1514-20. PubMed ID: 2776110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of liposarcomas-a study of 106 cases.
    Khan N; Ud Din H; Hashmi SN; Muhammad I; Atique M; Khadim T; Akhtar F
    J Ayub Med Coll Abbottabad; 2014; 26(3):320-2. PubMed ID: 25671937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposarcoma. A clinicopathologic subtyping of 52 cases.
    Hashimoto H; Enjoji M
    Acta Pathol Jpn; 1982 Nov; 32(6):933-48. PubMed ID: 6297235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.